[ad_1]
As published by “The Hill”, the US administration is preparing to take this possible step this week, to bypass some regulatory measures to implement the proposal faster.
A spokesman for the Department of Health and Human Services said: “We do not have any announcements at this time,” while the White House has not commented on the matter.
This proposal is similar to the ideas put forward by Democrats to reduce drug prices, increasing the likelihood that the Biden administration, if it does make it to the White House, will choose to continue with this program if it is actually implemented.
Trump has long criticized high drug prices in the United States, but none of his main proposals have been activated, while the report indicates that “they can emanate backlash from pharmaceutical companies, even going to court to bring cases that allow them to stop implementing the proposal. ” .
Many Republicans in Congress also oppose the proposal, warning that it does not fall within the free market principles of the traditional Republican Party and instead constitutes “price controls.”
And take advantage of this proposal if it applies to people who get prescription drugs through the “Medicare” program, and not to people who have health insurance through their jobs.
Last July, Trump signed 4 executive orders aimed at lowering prescription drug prices, allowing cheaper drugs to be imported from foreign countries, and requiring drug companies to grant discounts to patients, in addition to lowering the price of insulin and enforce the Medicare system. “The government buys the drugs at the prices other countries pay.
There is still the possibility that plans will change at the last minute, especially in light of the transition in the United States, after the mainstream media announced that Democratic candidate Joe Biden had won the presidency, although President Trump did not. recognized this result.
